
Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts
Author(s) -
Zhenfei Wang,
Da-Guang Ma,
Zhe Zhu,
Yongping Mu,
Yong-Yan Yang,
Feng Li,
Hao Yang,
Jing Liang,
Yong-Yan Liu,
Li Liu,
HaiWen Lu
Publication year - 2017
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v23.i48.8512
Subject(s) - microrna , astragaloside , cancer , cancer cell , fibroblast , cancer research , cell growth , wound healing , cell culture , sox2 , homeobox protein nanog , biology , microbiology and biotechnology , chemistry , immunology , medicine , biochemistry , embryonic stem cell , induced pluripotent stem cell , genetics , high performance liquid chromatography , chromatography , gene
To investigate the inhibitory effect of astragaloside IV on the pathological functions of cancer-associated fibroblasts, and to explore the underlying mechanism.